REFERENCES
- a)De Clercq, E. Strategies in the design of antiviral drugs. Nat. Rev. Drug Discov. 2002, 1, 13–25. b)De Clercq, E. Antiviral drugs in current clinical use. J. Clin. Virol. 2004, 30, 115–133.
- a)Galmarini, C.M.; Popowycz, F.; Joseph, B. Cytotoxic nucleoside analogues: different strategies to improve their clinical efficacy. Curr. Med. Chem. 2008, 15, 1072–1082. b)Galmarini, C.M.; Jordheim, L.; Dumontet, C. Pyrimidine nucleoside analogs in cancer treatment. Expert Rev. Anticancer Ther. 2003, 3, 717–728. c)Périgaud, C.; Gosselin, G.; Imbach, J.-L. Nucleoside analogues as chemotherapeutic agents: a review. Nucleos. Nucleot. 1992, 11, 903–945.
- Brunton, L.L. (Editor). Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th ed., McGraw-Hill Medical, New York, 2011, pp. 1628–1631 and 1638–1640.
- Dorland, E.; Serafinowski, P. A convenient method for the synthesis of 2′,3′-didehydro-2′,3′-dideoxy nucleosides. Synthesis 1992, 477–481.
- Robins, M.J.; Wilson, J.S.; Madej, D.; Low, N.H.; Hansske, F.; Wnuk, S.F. Nucleic acid related compounds. 88. Efficient conversions of ribonucleosides into their 2′,3′-anhydro, 2′ (and 3′)-deoxy, 2′,3′-didehydro-2′,3′-dideoxy, and 2′,3′-dideoxynucleoside analogues. J. Org. Chem. 1995, 60, 7902–7908.
- Wagner, C.R.; Iyer, V.V.; McIntee, E.J. Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides. Med. Res. Rev. 2000, 20, 417–451.
- Cahard, D.; McGuigan, C.; Balzarini, J. Aryloxy phosphoramidate triesters as pro-tides. Mini-Rev. Med. Chem. 2004, 4, 371–382.
- Hecker, S.J.; Erion, M.D. Prodrugs of phosphates and phosphonates. J. Med. Chem. 2008, 51, 2328–2345.
- Mehellou, Y.; Balzarini, J.; McGuigan, C. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells. Chem. Med. Chem. 2009, 4, 1779–1791.
- Bhat, V.; Stocker, E.; Ugarkar, B.G. A new synthesis of 2′,3′dideoxyinosine. Synth. Commun. 1992, 22, 1481–1486.
- Robins, M.J.; Hansske, F.; Low, N.H.; Park, J.I. A mild conversion of vicinal diols to alkenes. Efficient transformation of ribonucleosides into 2′-ene and 2′,3′dideoxynucleosides. Tetrahedron Lett. 1984, 25, 367–370.
- Itakura, K.; Katagiri, N.; Narang, S.A. Synthesis of lactose-operator gene fragments by the improved triester method. Can. J. Chem. 1974, 52, 3689–3693.
- McGuigan, C.; Cahard, D.; Sheeka, H.M.; De Clercq, E.; Balzarini, J. Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. J. Med. Chem. 1996, 39, 1748–1753.
- Stawiński, J.; Hozumi, T.; Narang, S.A.; Bahl, C.P.; Wu, R. Arylsulfonyltetrazoles, new coupling reagents and further improvements in the triester method for the synthesis of oligodeoxyribonucleotides. Nucleic Acids Res. 1977, 4, 353–371.
- Agarwal, K.L.; Riftina, F. Chemical synthesis of a self-complementary octanucleotide, dG-G-T-T-A-A-C-C by a modified triester method. Nucleic Acids Res. 1978, 5, 2809–2823.
- Chattopadhyaya, J.B.; Reese, C.B. Some observations relating to phosphorylation methods in oligonucleotide synthesis. Tetrahedron Lett. 1979, 5059–5062.
- Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107–1112.
- Yamaguchi, H.; Noshita, T.; Yu, T.; Kidachi, Y.; Kamiie, K.; Umetsu, H.; Ryoyama, K. Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity. Eur. J. Med. Chem. 2010, 45, 2943–2948.
- a)Pyka, A.; Babuska, M.; Zachariasz, M. A comparison of theoretical methods of calculation of partition coefficients for selected drugs. Acta Pol. Pharm. Drug Res. 2006, 63, 159–167. b)Meylan, W.M.; Howard, P.H. Atom/fragment contribution method for estimating octanol-water partition coefficients. J. Pharm. Sci. 1995, 84, 83–92.